期刊文献+

系统性红斑狼疮患者外周血MMP-2、MMP-3、MMP-9和TIMP-4水平的检测及其临床意义 被引量:2

Detection and the clinical significance of serum MMP-2、MMP-3、MMP-9 and TIMP-4 levels in patients with systemic lupus erythematosus
原文传递
导出
摘要 目的:检测系统性红斑狼疮(SLE)患者外周血基质金属蛋白酶(MMP)-2、MMP-3、MMP-9和基质金属蛋白酶组织型抑制因子(TIMP)-4的水平,并探讨其临床意义。方法:采用双抗夹心ELISA法,检测58例SLE患者及30例正常对照者的血清MMP-2、MMP-3、MMP-9和TIMP-4水平。结果:SLE患者血清MMP-3、TIMP-4水平显著高于正常对照者,但其血清MMP-2、MMP-9水平则与正常对照者间无统计学差异。SLE患者的血清MMP-3水平与MMP-2、MMP-9、TIMP-4水平均呈正相关,MMP-9水平与MMP-2水平间亦呈正相关;同时其MMP-2、MMP-3、MMP-9水平与反映肾脏、肝脏及机体免疫状态的多组指标间存在相关性,包括尿素氮、肌酐、尿酸、白蛋白、免疫球蛋白G、免疫球蛋白A、免疫球蛋白M、补体C3和补体C4等;SLE患者中,发生血小板减少者的血清MMP-2、MMP-9水平与血小板正常者相比显著降低。结论:SLE患者外周血MMP-3和TIMP-4水平显著升高。不同MMP间可相互调节,同时也受TIMP-4等TIMP的调节。MMP-2、MMP-3和MMP-9可能参与了SLE患者肾脏和肝脏的病理损害过程。 Objective To detect serum matrix metalloproteinase (MMP)-2, MMP-3, MMP-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-4 levels in patients with systemic lupus erythematosus (SLE) and define its clinical significance. Methods Serum levels of MMP-2, MMP-3, MMP-9 and TIMP-4 were measured by ELISA. Results Levels of MMP-3 and TIMP-4 were significantly higher in SLE patients than those in healthy controls. Positive correlation was found between these MMPs. Serum MMP-2, MMP-3, MMP-9 levels had a correlation with other laboratory results re- flecting the condition of kidney, liver and immunity. MMP-2 and MMP-9 levels were decreased in SLE patients having a low platelet count. Conclusins Serum MMP-2 and TIMP-4 levels are significantly higher in patients with SLE. MMP-2, MMP-3 and MMP-9 were regulated by a complicated network. TIMP-4 is involved in this network. MMP-2, MMP-3 and MMP-9 participate in the pathological process of kidney and liver impairment in SLE patients.
出处 《诊断学理论与实践》 2012年第4期397-400,共4页 Journal of Diagnostics Concepts & Practice
关键词 系统性红斑狼疮 基质金属蛋白酶 金属蛋白酶组织型抑制因子 酶联免疫吸附试验 Systemic lupus erythematosus Matrix metalloproteinase Tissue inhibitor of matrix metalloproteinase Enzyme-linked immunosorbent assay
  • 相关文献

参考文献6

  • 1Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior [J]. Annu Rev Cell Dev Biol, 2001,17:463-516.
  • 2Kotajima L, Aotsuka S, Fujimani M, et al. Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis [J]. Clin Exp Rheumatol, 1998,16(4):409-415.
  • 3Zueker S, Mian N, Drews M, et al. Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity [J]. J Rheumatol, 1999,26(1):78-80.
  • 4Chang YH, Lin IL, Tsay GJ, et al. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus[J]. Clin Biochem,2008,41 (12):955-959.
  • 5Faber-Elmann A, Sthoeger Z, Tcherniack A, et al. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus [J]. Clin Exp Immunol,2002,127(2):393-398.
  • 6Santos-Marttnez M J, Medina C, Jurasz P, et al. Role of metalloproteinases in platelet function [J]. Thromb Res, 2008,121 (4):535 -542.

同被引文献44

  • 1郭丽丽,陈言汤,牛扶幼,刘林嶓.病理性瘢痕组织中基质金属蛋白酶-1、金属蛋白酶组织抑制剂-1、血小板源性生长因子、增殖细胞核抗原的表达[J].郑州大学学报(医学版),2006,41(6):1027-1030. 被引量:4
  • 2Chakraborti S,Mandai M,Das S,et al.Regulation of matrix metalloproteinase:an overview[J].Molecular and Cellular Biochemistry,2003,253(1-2):269-285.
  • 3Roy R,Yang J,Moses MA.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer[J].J Clin Oncol,2009,27(31):5287-5297.
  • 4Kerkela E,Saarialho-Kere U.Matrix metalloproteinases in tumor progression:focus on basal and squamous cell skin cancer[J].Exp Dermatol,2003,12(2):109-125.
  • 5Kang S,Cho S,Chung JH,et al.Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo[J].American J of Pathol,2005,166(6):1691-1699.
  • 6Sato H,Takino T.Coordinate action of membrane-type matrix metalloproteinase-1(MT 1-MMP) and MMP-2 enhances pericellular proteolysis and invasion[J].Cancer Sci,2010,101(4):843-847.
  • 7Libra M,Scalisi A,Vella N,et al.Uterine cervical carcinoma:role of matrix metalloproteinases(review)[J].Int J Oncol,2009,34(4):897-903.
  • 8Waleh NS,Murphy BJ,Zaveri NT.Increase in tissue inhibitor of metalloproteinase-2(TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179[J].Cancer Lett,2010,289(1):111-118.
  • 9Johnson JL.Matrix metelloprteineses:influence on smooth muscle cells and atherosclerotic plaque stability[J].Expert Rev Cardiovasc Ther,2007,5(2):265-282.
  • 10Jalian HR,Liu PT,Kanchanapoomi M,et al.All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes[J].J Invest Dermatol,2008,128(12):2777-2782.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部